APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sophocarpidine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sophocarpidine Industry Growth and Trends Forecast to 2032

20 December 202592 pages

Choose your research edition.

Industry ResearchSophocarpidine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Sophocarpidine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Sophocarpidine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sophocarpidine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sophocarpidine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Sophocarpidine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sophocarpidine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sophocarpidine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sophocarpidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sophocarpidine include Fujie Pharmaceutical, Indena, Jiangsu Tiansheng Pharmaceutical, QHL Pharma, Selco Wirkstoffe Vertriebs GmbH, Select Botanical, TIANSHAN Pharmaceuticals, Hubei Zhongliao Chemical Co., LTD and Tiansheng Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sophocarpidine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sophocarpidine market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sophocarpidine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sophocarpidine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sophocarpidine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sophocarpidine Market by Company

Fujie Pharmaceutical

Indena

Jiangsu Tiansheng Pharmaceutical

QHL Pharma

Selco Wirkstoffe Vertriebs GmbH

Select Botanical

TIANSHAN Pharmaceuticals

Hubei Zhongliao Chemical Co., LTD

Tiansheng Pharmaceutical

Sophocarpidine Segment by Type

High Purity

Low Purity

Sophocarpidine Segment by Application

Pharmaceuticals

Pesticides

Others

Sophocarpidine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sophocarpidine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sophocarpidine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sophocarpidine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sophocarpidine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sophocarpidine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of High Purity Table 2. Major Company of Low Purity Table 3. Global Sophocarpidine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Sophocarpidine Sales by Type (2021-2026) & (K Tons) Table 5. Global Sophocarpidine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Sophocarpidine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Sophocarpidine Sales Market Share in Value by Type (2021-2026) Table 8. Global Sophocarpidine Price by Type (2021-2026) & (US$/Ton) Table 9. Global Sophocarpidine Sales by Type (2027-2032) & (K Tons) Table 10. Global Sophocarpidine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Sophocarpidine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Sophocarpidine Sales Market Share in Value by Type (2027-2032) Table 13. Global Sophocarpidine Price by Type (2027-2032) & (US$/Ton) Table 14. North America Sophocarpidine Sales by Type (2021-2026) & (K Tons) Table 15. North America Sophocarpidine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Sophocarpidine Sales by Type (2021-2026) & (K Tons) Table 17. Europe Sophocarpidine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Sophocarpidine Sales by Type (2021-2026) & (K Tons) Table 19. Asia-Pacific Sophocarpidine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Sophocarpidine Sales by Type (2021-2026) & (K Tons) Table 21. Latin America Sophocarpidine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Sophocarpidine Sales by Type (2021-2026) & (K Tons) Table 23. Middle East and Africa Sophocarpidine Sales by Type (2021-2026) & (US$ Million) Table 24. Sophocarpidine Industry Trends Table 25. Sophocarpidine Industry Drivers Table 26. Sophocarpidine Industry Opportunities and Challenges Table 27. Sophocarpidine Industry Restraints Table 28. Global Sophocarpidine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Sophocarpidine Revenue Market Share by Company (2021-2026) Table 30. Global Sophocarpidine Sales by Company (2021-2026) & (K Tons) Table 31. Global Sophocarpidine Sales Share by Company (2021-2026) Table 32. Global Sophocarpidine Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Sophocarpidine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Sophocarpidine Major Company Production Sites and Headquarters Table 35. Global Sophocarpidine Company, Product Type & Application Table 36. Global Sophocarpidine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Sophocarpidine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Sophocarpidine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Sophocarpidine Sales by Region (2021-2026) & (K Tons) Table 41. Global Sophocarpidine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Sophocarpidine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Sophocarpidine Sales Market Share in Value by Region (2021-2026) Table 44. Global Sophocarpidine Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Sophocarpidine Sales by Region (2027-2032) & (K Tons) Table 46. Global Sophocarpidine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Sophocarpidine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Sophocarpidine Sales Market Share in Value by Region (2027-2032) Table 49. Global Sophocarpidine Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Sophocarpidine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Sophocarpidine Sales by Application (2021-2026) & (K Tons) Table 52. Global Sophocarpidine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Sophocarpidine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Sophocarpidine Sales Market Share in Value by Application (2021-2026) Table 55. Global Sophocarpidine Price by Application (2021-2026) & (US$/Ton) Table 56. Global Sophocarpidine Sales by Application (2027-2032) & (K Tons) Table 57. Global Sophocarpidine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Sophocarpidine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Sophocarpidine Sales Market Share in Value by Application (2027-2032) Table 60. Global Sophocarpidine Price by Application (2027-2032) & (US$/Ton) Table 61. North America Sophocarpidine Sales by Application (2021-2026) & (K Tons) Table 62. North America Sophocarpidine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Sophocarpidine Sales by Application (2021-2026) & (K Tons) Table 64. Europe Sophocarpidine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Sophocarpidine Sales by Application (2021-2026) & (K Tons) Table 66. Asia-Pacific Sophocarpidine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Sophocarpidine Sales by Application (2021-2026) & (K Tons) Table 68. Latin America Sophocarpidine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Sophocarpidine Sales by Application (2021-2026) & (K Tons) Table 70. Middle East and Africa Sophocarpidine Sales by Application (2021-2026) & (US$ Million) Table 71. Fujie Pharmaceutical Company Information Table 72. Fujie Pharmaceutical Business Overview Table 73. Fujie Pharmaceutical Sophocarpidine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Fujie Pharmaceutical Sophocarpidine Product Portfolio Table 75. Fujie Pharmaceutical Recent Development Table 76. Indena Company Information Table 77. Indena Business Overview Table 78. Indena Sophocarpidine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Indena Sophocarpidine Product Portfolio Table 80. Indena Recent Development Table 81. Jiangsu Tiansheng Pharmaceutical Company Information Table 82. Jiangsu Tiansheng Pharmaceutical Business Overview Table 83. Jiangsu Tiansheng Pharmaceutical Sophocarpidine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Jiangsu Tiansheng Pharmaceutical Sophocarpidine Product Portfolio Table 85. Jiangsu Tiansheng Pharmaceutical Recent Development Table 86. QHL Pharma Company Information Table 87. QHL Pharma Business Overview Table 88. QHL Pharma Sophocarpidine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. QHL Pharma Sophocarpidine Product Portfolio Table 90. QHL Pharma Recent Development Table 91. Selco Wirkstoffe Vertriebs GmbH Company Information Table 92. Selco Wirkstoffe Vertriebs GmbH Business Overview Table 93. Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Product Portfolio Table 95. Selco Wirkstoffe Vertriebs GmbH Recent Development Table 96. Select Botanical Company Information Table 97. Select Botanical Business Overview Table 98. Select Botanical Sophocarpidine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Select Botanical Sophocarpidine Product Portfolio Table 100. Select Botanical Recent Development Table 101. TIANSHAN Pharmaceuticals Company Information Table 102. TIANSHAN Pharmaceuticals Business Overview Table 103. TIANSHAN Pharmaceuticals Sophocarpidine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. TIANSHAN Pharmaceuticals Sophocarpidine Product Portfolio Table 105. TIANSHAN Pharmaceuticals Recent Development Table 106. Hubei Zhongliao Chemical Co., LTD Company Information Table 107. Hubei Zhongliao Chemical Co., LTD Business Overview Table 108. Hubei Zhongliao Chemical Co., LTD Sophocarpidine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Hubei Zhongliao Chemical Co., LTD Sophocarpidine Product Portfolio Table 110. Hubei Zhongliao Chemical Co., LTD Recent Development Table 111. Tiansheng Pharmaceutical Company Information Table 112. Tiansheng Pharmaceutical Business Overview Table 113. Tiansheng Pharmaceutical Sophocarpidine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Tiansheng Pharmaceutical Sophocarpidine Product Portfolio Table 115. Tiansheng Pharmaceutical Recent Development Table 116. North America Sophocarpidine Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 117. North America Sophocarpidine Sales by Country (2021-2026) & (K Tons) Table 118. North America Sophocarpidine Sales Market Share by Country (2021-2026) Table 119. North America Sophocarpidine Sales Forecast by Country (2027-2032) & (K Tons) Table 120. North America Sophocarpidine Sales Market Share Forecast by Country (2027-2032) Table 121. North America Sophocarpidine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Sophocarpidine Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Sophocarpidine Market Share by Country (2021-2026) Table 124. North America Sophocarpidine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Sophocarpidine Market Share Forecast by Country (2027-2032) Table 126. Europe Sophocarpidine Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 127. Europe Sophocarpidine Sales by Country (2021-2026) & (K Tons) Table 128. Europe Sophocarpidine Sales Market Share by Country (2021-2026) Table 129. Europe Sophocarpidine Sales Forecast by Country (2027-2032) & (K Tons) Table 130. Europe Sophocarpidine Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Sophocarpidine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Sophocarpidine Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Sophocarpidine Market Share by Country (2021-2026) Table 134. Europe Sophocarpidine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Sophocarpidine Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Sophocarpidine Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Sophocarpidine Sales by Country (2021-2026) & (K Tons) Table 138. Asia-Pacific Sophocarpidine Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Sophocarpidine Sales Forecast by Country (2027-2032) & (K Tons) Table 140. Asia-Pacific Sophocarpidine Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Sophocarpidine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Sophocarpidine Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Sophocarpidine Market Share by Country (2021-2026) Table 144. Asia-Pacific Sophocarpidine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Sophocarpidine Market Share Forecast by Country (2027-2032) Table 146. Latin America Sophocarpidine Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 147. Latin America Sophocarpidine Sales by Country (2021-2026) & (K Tons) Table 148. Latin America Sophocarpidine Sales Market Share by Country (2021-2026) Table 149. Latin America Sophocarpidine Sales Forecast by Country (2027-2032) & (K Tons) Table 150. Latin America Sophocarpidine Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Sophocarpidine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Sophocarpidine Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Sophocarpidine Market Share by Country (2021-2026) Table 154. Latin America Sophocarpidine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Sophocarpidine Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Sophocarpidine Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Sophocarpidine Sales by Country (2021-2026) & (K Tons) Table 158. Middle East and Africa Sophocarpidine Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Sophocarpidine Sales Forecast by Country (2027-2032) & (K Tons) Table 160. Middle East and Africa Sophocarpidine Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Sophocarpidine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Sophocarpidine Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Sophocarpidine Market Share by Country (2021-2026) Table 164. Middle East and Africa Sophocarpidine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Sophocarpidine Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Sophocarpidine Distributors List Table 169. Sophocarpidine Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Sophocarpidine Image Figure 2. Global Sophocarpidine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sophocarpidine Market Size (2021-2032) & (US$ Million) Figure 4. Global Sophocarpidine Sales (2021-2032) & (K Tons) Figure 5. High Purity Image Figure 6. Global High Purity Sales YoY Growth (2021-2032) & (K Tons) Figure 7. Low Purity Image Figure 8. Global Low Purity Sales YoY Growth (2021-2032) & (K Tons) Figure 9. Global Sophocarpidine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Sophocarpidine Market Share by Type 2025 VS 2032 Figure 11. North America Sophocarpidine Sales Market Share in Volume by Type in 2025 Figure 12. North America Sophocarpidine Sales Market Share in Value by Type in 2025 Figure 13. Europe Sophocarpidine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Sophocarpidine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Sophocarpidine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Sophocarpidine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Sophocarpidine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Sophocarpidine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Sophocarpidine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Sophocarpidine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Sophocarpidine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pharmaceuticals Image Figure 24. Global Pharmaceuticals Sales YoY Growth (2021-2032) & (K Tons) Figure 25. Pesticides Image Figure 26. Global Pesticides Sales YoY Growth (2021-2032) & (K Tons) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Tons) Figure 29. Global Sophocarpidine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Sophocarpidine Market Share by Application 2025 VS 2032 Figure 31. North America Sophocarpidine Sales Market Share in Volume by Application in 2025 Figure 32. North America Sophocarpidine Sales Market Share in Value by Application in 2025 Figure 33. Europe Sophocarpidine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Sophocarpidine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Sophocarpidine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Sophocarpidine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Sophocarpidine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Sophocarpidine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Sophocarpidine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Sophocarpidine Sales Market Share in Value by Application in 2025 Figure 41. North America Sophocarpidine Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 42. North America Sophocarpidine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Sophocarpidine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Sophocarpidine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Sophocarpidine Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 46. Europe Sophocarpidine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Sophocarpidine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Sophocarpidine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Sophocarpidine Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 50. Asia-Pacific Sophocarpidine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Sophocarpidine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Sophocarpidine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Sophocarpidine Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 54. Latin America Sophocarpidine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Sophocarpidine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Sophocarpidine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Sophocarpidine Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 58. Middle East and Africa Sophocarpidine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Sophocarpidine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Sophocarpidine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Sophocarpidine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Sophocarpidine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • High Purity
  • Low Purity
Applications
  • Pharmaceuticals
  • Pesticides
  • Others
Companies covered
  • Fujie Pharmaceutical
  • Indena
  • Jiangsu Tiansheng Pharmaceutical
  • QHL Pharma
  • Selco Wirkstoffe Vertriebs GmbH
  • Select Botanical
  • TIANSHAN Pharmaceuticals
  • Hubei Zhongliao Chemical Co., LTD
  • Tiansheng Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sophocarpidine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sophocarpidine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sophocarpidine Market by Type
  6. 1.3.1 High Purity
  7. 1.3.2 Low Purity
  8. 1.4 Global Sophocarpidine Market Size by Type
  9. 1.4.1 Global Sophocarpidine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Sophocarpidine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Sophocarpidine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Sophocarpidine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Sophocarpidine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Sophocarpidine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Sophocarpidine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Sophocarpidine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sophocarpidine Industry Trends
  2. 2.2 Sophocarpidine Industry Drivers
  3. 2.3 Sophocarpidine Industry Opportunities and Challenges
  4. 2.4 Sophocarpidine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sophocarpidine Revenue (2021-2026)
  2. 3.2 Global Top Players by Sophocarpidine Sales (2021-2026)
  3. 3.3 Global Top Players by Sophocarpidine Price (2021-2026)
  4. 3.4 Global Sophocarpidine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sophocarpidine Major Company Production Sites & Headquarters
  6. 3.6 Global Sophocarpidine Company, Product Type & Application
  7. 3.7 Global Sophocarpidine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sophocarpidine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sophocarpidine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sophocarpidine Tier 1, Tier 2, and Tier 3
4 Sophocarpidine Regional Status and Outlook
  1. 4.1 Global Sophocarpidine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sophocarpidine Historic Market Size by Region
  3. 4.2.1 Global Sophocarpidine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sophocarpidine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sophocarpidine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sophocarpidine Forecasted Market Size by Region
  7. 4.3.1 Global Sophocarpidine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sophocarpidine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sophocarpidine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sophocarpidine by Application
  1. 5.1 Sophocarpidine Market by Application
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Pesticides
  4. 5.1.3 Others
  5. 5.2 Global Sophocarpidine Market Size by Application
  6. 5.2.1 Global Sophocarpidine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Sophocarpidine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Sophocarpidine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Sophocarpidine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Sophocarpidine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Sophocarpidine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Sophocarpidine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Sophocarpidine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Fujie Pharmaceutical
  2. 6.1.1 Fujie Pharmaceutical Company Information
  3. 6.1.2 Fujie Pharmaceutical Business Overview
  4. 6.1.3 Fujie Pharmaceutical Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Fujie Pharmaceutical Sophocarpidine Product Portfolio
  6. 6.1.5 Fujie Pharmaceutical Recent Developments
  7. 6.2 Indena
  8. 6.2.1 Indena Company Information
  9. 6.2.2 Indena Business Overview
  10. 6.2.3 Indena Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Indena Sophocarpidine Product Portfolio
  12. 6.2.5 Indena Recent Developments
  13. 6.3 Jiangsu Tiansheng Pharmaceutical
  14. 6.3.1 Jiangsu Tiansheng Pharmaceutical Company Information
  15. 6.3.2 Jiangsu Tiansheng Pharmaceutical Business Overview
  16. 6.3.3 Jiangsu Tiansheng Pharmaceutical Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Tiansheng Pharmaceutical Sophocarpidine Product Portfolio
  18. 6.3.5 Jiangsu Tiansheng Pharmaceutical Recent Developments
  19. 6.4 QHL Pharma
  20. 6.4.1 QHL Pharma Company Information
  21. 6.4.2 QHL Pharma Business Overview
  22. 6.4.3 QHL Pharma Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 QHL Pharma Sophocarpidine Product Portfolio
  24. 6.4.5 QHL Pharma Recent Developments
  25. 6.5 Selco Wirkstoffe Vertriebs GmbH
  26. 6.5.1 Selco Wirkstoffe Vertriebs GmbH Company Information
  27. 6.5.2 Selco Wirkstoffe Vertriebs GmbH Business Overview
  28. 6.5.3 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine Product Portfolio
  30. 6.5.5 Selco Wirkstoffe Vertriebs GmbH Recent Developments
  31. 6.6 Select Botanical
  32. 6.6.1 Select Botanical Company Information
  33. 6.6.2 Select Botanical Business Overview
  34. 6.6.3 Select Botanical Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Select Botanical Sophocarpidine Product Portfolio
  36. 6.6.5 Select Botanical Recent Developments
  37. 6.7 TIANSHAN Pharmaceuticals
  38. 6.7.1 TIANSHAN Pharmaceuticals Company Information
  39. 6.7.2 TIANSHAN Pharmaceuticals Business Overview
  40. 6.7.3 TIANSHAN Pharmaceuticals Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 TIANSHAN Pharmaceuticals Sophocarpidine Product Portfolio
  42. 6.7.5 TIANSHAN Pharmaceuticals Recent Developments
  43. 6.8 Hubei Zhongliao Chemical Co., LTD
  44. 6.8.1 Hubei Zhongliao Chemical Co., LTD Company Information
  45. 6.8.2 Hubei Zhongliao Chemical Co., LTD Business Overview
  46. 6.8.3 Hubei Zhongliao Chemical Co., LTD Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hubei Zhongliao Chemical Co., LTD Sophocarpidine Product Portfolio
  48. 6.8.5 Hubei Zhongliao Chemical Co., LTD Recent Developments
  49. 6.9 Tiansheng Pharmaceutical
  50. 6.9.1 Tiansheng Pharmaceutical Company Information
  51. 6.9.2 Tiansheng Pharmaceutical Business Overview
  52. 6.9.3 Tiansheng Pharmaceutical Sophocarpidine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Tiansheng Pharmaceutical Sophocarpidine Product Portfolio
  54. 6.9.5 Tiansheng Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Sophocarpidine Sales by Country
  2. 7.1.1 North America Sophocarpidine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sophocarpidine Sales by Country (2021-2026)
  4. 7.1.3 North America Sophocarpidine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sophocarpidine Market Size by Country
  6. 7.2.1 North America Sophocarpidine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sophocarpidine Market Size by Country (2021-2026)
  8. 7.2.3 North America Sophocarpidine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sophocarpidine Sales by Country
  2. 8.1.1 Europe Sophocarpidine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sophocarpidine Sales by Country (2021-2026)
  4. 8.1.3 Europe Sophocarpidine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sophocarpidine Market Size by Country
  6. 8.2.1 Europe Sophocarpidine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sophocarpidine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sophocarpidine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sophocarpidine Sales by Country
  2. 9.1.1 Asia-Pacific Sophocarpidine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sophocarpidine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sophocarpidine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sophocarpidine Market Size by Country
  6. 9.2.1 Asia-Pacific Sophocarpidine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sophocarpidine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sophocarpidine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sophocarpidine Sales by Country
  2. 10.1.1 South America Sophocarpidine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sophocarpidine Sales by Country (2021-2026)
  4. 10.1.3 South America Sophocarpidine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sophocarpidine Market Size by Country
  6. 10.2.1 South America Sophocarpidine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sophocarpidine Market Size by Country (2021-2026)
  8. 10.2.3 South America Sophocarpidine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sophocarpidine Sales by Country
  2. 11.1.1 Middle East and Africa Sophocarpidine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sophocarpidine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sophocarpidine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sophocarpidine Market Size by Country
  6. 11.2.1 Middle East and Africa Sophocarpidine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sophocarpidine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sophocarpidine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sophocarpidine Value Chain Analysis
  2. 12.1.1 Sophocarpidine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sophocarpidine Production Mode & Process
  7. 12.2 Sophocarpidine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sophocarpidine Distributors
  10. 12.2.3 Sophocarpidine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst